LLR Partners, Quaker Carve Out Medmark.

As the lines between venture capital and buyouts continue to blur, LLR Partners and Quaker BioVentures agreed to partner up in the acquisition of specialty pharmaceutical company Medmark. The team paid $28 million to grab a control stake in the business from healthcare insurer Highmark, which launched the business with the acquisition of Fisher’s Specialized Pharmacy Services in October last year.

While the buyout community tends to keep its distance from biotech deals and VC shies away from larger control investments, the pairing of LLR and Quaker to buy Medmark fits well for …

COPYRIGHT 2004 Gale Group

You May Also Like

A new lease of life: the IEA forecasts a rise in Canadian oil-sands production of 1m b/d by 2010. The energy-hungry US is the target for the increased output, as it seeks alternative oil supply sources. US companies are getting in

A new lease of life: the IEA forecasts a rise in Canadian oil-sands production of 1m b/d by 2010. The energy-hungry US is the target for the inc…

Harrison, N.J.-Based Housewares Retailer Files for Bankruptcy

Harrison, N.J.-Based Housewares Retailer Files for Bankruptcy By Lauren Coleman-Lochner Lechters Inc. filed for voluntary Chapter 11…

Development advantages in Ningbo Chemical Industry Zone.

Development advantages in Ningbo Chemical Industry Zone. Ningbo Chemical Industry Zone is the only chemical industry zone in Ningbo, Zheji…

Operators put stake on social responsibility.

Operators put stake on social responsibility. The gambling industry is making good progress in its bid to allay government and public conc…